share_log

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee With VINIA Inside

BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee With VINIA Inside

BioHarvest Sciences累計直銷咖啡銷售額突破100萬美元,其中含有VINIA
newsfile ·  08/28 09:56

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its VINIA Superfood Coffee and Decaf Coffee, a "functional" coffee product line integrating flagship nutraceutical product VINIA Red Grape Superfood into a premium coffee in the popular Keurig compatible pod format, has surpassed USD $1.0 million in cumulative sales since its launch in December 2023.

溫哥華,卑詩省和以色列雷霍沃特-(新聞稿特快社-2024年8月28日)-BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF)(以下簡稱「BioHarvest」或「公司」),一家以其專利植物綜合技術平台爲先導的公司,今天宣佈,自2023年12月推出以來,其VINIA超級食品咖啡和無咖啡因咖啡已累計銷售超過100萬美元。該產品系列將旗艦營養產品VINIA紅葡萄超級食品與受歡迎的Keurig兼容的咖啡製成了高端咖啡豆。


Photo of 30 Day Supply of VINIA Superfood Coffee


VINIA超級食品咖啡30天供應照片

VINIA Superfood Coffee is made with premium 100% Arabica beans and features the flagship VINIA matrix of red grape polyphenols that improves physical energy and mental alertness via increased dilation of arteries and blood flow when consumed daily for 90 days. Each Medium Roast and Decaf VINIA Superfood Coffee Pod includes VINIA Red Grape Powder (23 mg of polyphenols including 6 mg of piceid resveratrol) which is equivalent to one VINIA capsule. VINIA Superfood Coffee K-Cup pods are compatible with Keurig and most single serve brewing systems.

VINIA超級食品咖啡採用優質100%阿拉比卡咖啡豆製成,具有旗艦VINIA紅葡萄多酚基質,通過增加動脈和血流的擴張,每天飲用90天可以改善身體能量和提高警覺性。每個中焙和無咖啡因VINIA超級食品咖啡Pod包括VINIA紅葡萄粉(23毫克多酚,包括6毫克的種皮白藜蘆醇),相當於一個VINIA膠囊。VINIA超級食品咖啡k-Cup咖啡Pod與Keurig和大多數單杯沖泡系統兼容。

Since launch, VINIA Superfood Coffee has achieved a best-in-class verified customer rating via its website of 4.8 out of 5.0 with over 136 verified reviews, demonstrating its significant positive impact on consumers' lives.**

自推出以來,VINIA超級食品咖啡在其網站上獲得了最佳驗證顧客評分,4.8分(滿分爲5分),並擁有1.36個經過驗證的評價,表明其對消費者生活的重要積極影響。**

In a blind taste-test of coffee drinkers (N=76), 59% of coffee drinkers prefer VINIA Superfood Coffee when compared to a leading "Better for You" national coffee brand competitor. In a blind taste-test of decaf coffee drinkers (N=60), more than 2 out of 3 (68%) preferred VINIA Superfood Decaf over a leading decaf brand sold on Amazon.

在一個盲品測試中(N=76),有59%的咖啡飲用者更喜歡VINIA超級食品咖啡,相比之下,一家領先的「更適合您」的全國咖啡品牌競爭對手。在一個無咖啡因咖啡飲用者的盲品測試中(N=60),超過2/3的人(68%)喜歡VINIA超級食品無咖啡因咖啡,而不是在亞馬遜上銷售的一家領先的無咖啡因咖啡品牌。

"Our strategy to enter major categories seeking innovation, where consumers are demanding more functionality and health and wellness solutions, has been validated by the strong sales of our recently launched VINIA Superfood Coffees with its Superior Science, Superior Efficacy and Superior Taste strategy," said Ilan Sobel, CEO of BioHarvest Sciences. "We have made significant progress in just a few months in our efforts to gain market share in the Functional Coffee market, amid rising consumer demand for coffee solutions with increased health benefits. VINIA Hot Beverages expands usage occasions for VINIA, increases our user base with younger audiences, and provides higher gross profit per equivalent unit.

BioHarvest Sciences的首席執行官Ilan Sobel表示: "我們進入尋求創新的主要類別,並在消費者對功能性和健康和福祉解決方案需求更高的領域,通過我們最近推出的VINIA超級食品咖啡的出色科學、出色功效和出色口感策略的強銷業績,我們得到了驗證。在功能性咖啡市場上,我們在短短几個月內在市場份額的爭奪方面取得了顯著進展,這是在消費者對具有增加健康效益的咖啡解決方案的需求不斷上升的背景下實現的。VINIA熱飲擴大了VINIA的使用場合,通過更年輕的受衆群提高了我們的用戶基數,並提供更高的毛利潤每個等價單位。"

"Looking ahead for the Hot Beverages business, we expect to add new Nespresso compatible pods with VINIA Superfood Coffee before year end, which has received blind taste test parity with a major Nespresso line amongst espresso coffee drinkers. Today's $1.0 million milestone for VINIA Superfood Coffee continues to demonstrate our powerful direct marketing and sales platform. We believe its rapid success will power additional monthly sales gains in the months to come as we grow our Hot Beverage portfolio and Product Business Unit," concluded Sobel.

展望熱飲業務,我們預計在年底之前將推出使用VINIA超級食品咖啡的新款Nespresso兼容咖啡豆。這款咖啡經過盲品測試,與一款主要的Nespresso咖啡系列在濃縮咖啡飲用者中達到了口感的平衡。今天,VINIA超級食品咖啡突破了100萬美元的里程碑,繼續展現出我們強大的直銷和銷售平台的力量。我們相信它的快速成功將爲未來幾個月的銷售增長提供動力,因爲我們不斷擴大我們的熱飲產品組合和產品業務部門。

In Q1 2024, the first full quarter following the introduction of VINIA Coffees, Gross profit was US$3.0 million, or 56% of total Product revenues, as compared to US$0.8 million, or 37% of total Product revenues in the same period in the prior financial year. Those Product revenues were generated by sales of VINIA capsules and VINIA coffees. Gross margin represents the percentage of revenue that exceeds the cost of goods sold, calculated as gross profit divided by revenue. Net loss for the first quarter of fiscal 2024 totaled US$6.6 million.

在2024財年第一季度,VINIA咖啡推出後的第一個完整季度,毛利潤爲300萬美元,佔產品總營收的56%,而上一財年同期的產品總營收爲80萬美元,佔總營收的37%。這些產品銷售收入來自VINIA膠囊和VINIA咖啡的銷售。毛利率代表超過銷售成本的收入百分比,計算公式爲毛利潤除以營業收入。2024財年第一季度的淨損失總計爲660萬美元。

* The Global Functional Coffee Market is estimated to be $4.03 Billion USD in 2024. Source: Functional Coffee Market - Trends, Size & Industry Analysis (mordorintelligence.com)
* The Global Functional Tea Market is estimated to be $8.1 Billion in 2024. Source: Functional Tea Market Size, Share, Growth and Forecast - 2032 (marketresearchfuture.com)
** BioHarvest Sciences encourages all product customers to leave honest and uncensored feedback. Product customers receive a 30-day supply when they submit a review, whether positive or negative.

*2024年全球功能性咖啡市場預計爲40.3億美元。來源:Functional Coffee Market - Trends, Size & Industry Analysis (mordorintelligence.com)
*2024年全球功能性茶市場預計爲81億美元。來源:Functional Tea Market Size, Share, Growth and Forecast - 2032 (marketresearchfuture.com)
**BioHarvest Sciences鼓勵所有產品顧客留下真實和不受審查的反饋。客戶在提交評論後將收到30天的供應量,無論是積極的還是消極的。

About BioHarvest Sciences Inc.

BioHarvest Sciences Inc.簡介

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit .

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV)是植物合成領域的領導者,利用其專利技術平台培育植物基分子,無需種植底層植物。BioHarvest利用其植物合成技術在兩個主要的業務垂直領域開發下一代基於科學和經過臨床驗證的治療解決方案;作爲一家代表尋求複雜分子的客戶的合同開發和生產組織(CDMO),以及作爲專有營養保健產品和膳食補充劑的創造者。了解更多信息,請訪問。

Forward-Looking Statements

前瞻性聲明

Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Launching new products is subject to risks and uncertainties including the risk that the market will not accept the product or that government approvals required for sale or import of the products will not be obtained. There is never an assurance that any product set will successfully disrupt established product categories. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.

此新聞稿中提供的信息可能包含基於管理層當前估計、信念、意圖和預期的前瞻性陳述,受許多風險和不確定性影響,這些風險和不確定性可能導致實際結果與前瞻性陳述中描述的結果有實質性差異。推出新產品面臨風險和不確定性,包括市場可能不接受該產品或政府可能不會批准銷售或進口該產品。無法保證任何產品組合能成功顛覆現有產品類別。所有前瞻性陳述本質上都存在不確定性,實際結果可能受到我們無法控制的多個重要因素的影響。讀者不應過分依賴前瞻性陳述。BHSC無意通過我們的常規管理討論和分析披露更新前瞻性陳述。

*Note: VINIA has no affiliation with Keurig Dr. Pepper Inc. or Nespresso. "Keurig" and "K-Cup" are registered trademarks of Keurig Dr. Pepper Inc.

*注意:VINIA與Keurig Dr. Pepper Inc.或Nespresso沒有任何關聯。"Keurig"和"k-Cup"是Keurig Dr. Pepper Inc.的註冊商標。

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.

加拿大證券交易所及其規定服務供應商對本聲明的充分性或準確性不承擔任何責任。

This release has been reviewed and approved by Dave Ryan, VP Investor Relations, who accepts responsibilities for its contents.

此新聞稿內容已由Dave Ryan, VP Investor Relations審核並批准。

BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations & Director
+1 (604) 622-1186
info@bioharvest.com

BioHarvest的公司聯繫方式:
Dave Ryan,投資者關係和董事副總裁
+1 (604) 622-1186
info@bioharvest.com

Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us

投資者關係聯繫人:
Lucas A. Zimmerman
董事總經理
MZ Group - MZ North America
+1 (949) 259-4987
BHSC@mzgroup.us

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論